M&A Deal Summary |
|
|---|---|
| Date | 2024-05-20 |
| Target | Fluidic Analytics |
| Sector | Medical Products |
| Buyer(s) | Fluidic Sciences |
| Deal Type | Special Situations/Distressed |
SEARCH BY
Fluidic Sciences make protein interaction analysis easy and robust, by developing transformative in-solution technologies and accessible instruments that help scientists quickly and accurately understand how proteins truly interact. Fluidic Sciences is based in Royston, United Kingdom.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 2 |
| Sector: Medical Products M&A | 1 of 1 |
| Type: Special Situations/Distressed M&A Deals | 1 of 1 |
| Country: United Kingdom M&A | 1 of 2 |
| Year: 2024 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2025-09-02 |
Sphere Bio
Cambridge, United Kingdom Sphere Bio is a life sciences tools company developing high-throughput single-cell analysis technologies using proprietary picodroplet microfluidics. Its Cyto-Mine® platforms accelerate biologics discovery, cell line development, and cell therapy research for global biopharma and biotech companies. Sphere Bio is based in Cambridge, United Kingdom. |
Buy | - |
